EWS/ETS fusion genes induce epithelial and neuroectodermal differentiation in NIH 3T3 fibroblasts

Laboratory Investigation

Volumn 79, Issue 12, 1999, Pages 1535-1543

  Teitell, Michael A ^a,b,d   Thompson, Andrew D ^a,b   Sorensen, Poul H B ^c   Shimada, Hiroyuki ^d   Triche, Timothy J ^d   Denny, Christopher T ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BC CHILDREN S HOSPITAL   (Canada)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; ENDOPLASMIC RETICULUM; EPITHELIUM CELL; EWING SARCOMA; FIBROBLAST; FUSION GENE; GENE EXPRESSION REGULATION; GENE INDUCTION; MALIGNANT TRANSFORMATION; MOUSE; NEUROECTODERM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; RECEPTOR UPREGULATION;

3T3 CELLS; ANIMALS; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; ECTODERM; EPITHELIAL CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; IMMUNOHISTOCHEMISTRY; MICE; MICE, SCID; NEOPLASM INVASIVENESS; NEUROECTODERMAL TUMORS, PRIMITIVE; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RIBONUCLEOPROTEINS; RNA-BINDING PROTEIN EWS; SARCOMA, EWING'S; TRANSCRIPTION FACTORS;

EID: 0033398391     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Angervall L and Enzinger FM (1975). Extraskeletal neoplasm resembling Ewing's sarcoma. Cancer 36:240-251.
2. Arvand A, Bastians H, Welford SM, Thompson AD, Ruderman JV, and Denny CT (1998). EWS/FLI1 up-regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction. Oncogene 17:2039-2045.
3. Auvinen M, Laine A, Paasinen-Sohns A, Kangas A, Kangas L, Saksela O, Andersson LC, and Holtta E (1997). Human ornithine decarboxylase-over producing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Cancer Res 57:3016-3025.
4. Bernstein SC and Weinberg RA (1985). Expression of the metastatic phenotype in cells transfected with human metastatic tumor DNA. Proc Natl Acad Sci USA 82:1726-1730.
5. Bertolotti A, Melot T, Acker J, Vigneron M, Delattre O, and Tora L (1998). EWS, but not EWS/FLI1, is associated with both TFIID and RNA polymerase II: Interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. Mol Cell Biol 18:1489-1497.
6. Braun BS, Frieden R, Lessnick SL, May WA, and Denny CT (1995). Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis. Mol Cell Biol 15:4623-4630.
7. Bridge JA, Fidler ME, Neff JR, Degenhardt J, Wang M, Walker C, Dorfman HD, Baker KS, and Seemayer TA (1999). Adamantinoma-like Ewing's sarcoma: Genomic confirmation, phenotypic drift. Am J Surg Path 23:159-165.
8. Cardinali M, Kratochvil FJ, Ensley JF, Robbins KC, and Yeudall WA (1997). Functional characterization in vivo of mutant p53 molecules derived from squamous cell carcinomas of the head and neck. Mol Carcinogen 18:78-88.
9. Cate CC, Belloni DR, and Marin-Padilla M (1995). Acquisition and enhanced expression of the metastatic phenotype after transfections of genomic mouse tumor DNA containing human SCLC gene sequences. Clin Exp Metastasis 13:203-217.
10. Dehner LP (1993). Primitive neuroectodermal tumor and Ewing's sarcoma. Am J Surg Path 17:1-13.
11. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A, and Thomas G (1992). Gene fusion with an ETS DNA-binding domain caused by chromosomal translocation in human tumours. Nature 359:162-165.
12. Delattre O, Zucman J, Melot T, Garau XS, Zucker J-M, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ, Aurias A, and Thomas G (1994). The Ewing family of tumors: A subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Eng J Med 331:294-299.
13. Dellagi K, Lipinski M, Paulin D, Portier MM, Lenoir GM, and Brauet JC (1987). Characterization of intermediate filaments expressed by Ewing tumor cell lines. Cancer Res 47:1170-1173.
14. Del Paso L, Hernandez-Alcoceba R, Embade N, Carnero A, Esteve P, Paje C, and Lacal JC (1997). Rho proteins induce metastatic properties in vivo. Oncogene 15:3047-3057.
15. Denny CT (1996). Gene rearrangements in Ewing's sarcoma. Can Invest 14:83-88.
16. Denny CT (1998). Ewing's sarcoma: A clinical enigma coming into focus. J Ped Hem/Oncol 20:1-5.
17. Erlandson RA (1987). The ultrastructural distinction between rhabdomyosarcoma and other undifferentiated "sarcomas." Ultra Path 11:83-101.
18. Ichikawa H, Shimizu K, Hayashi Y, and Ohki M (1994). An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with a t(16;21) chromosomal translocation. Cancer Res 54:2865-2868.
19. Jeon I-S, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, and Shapiro DN (1995). A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10:1229-1234.
20. Kaneko Y, Yoshida K, Handa M, Toyoda Y, Nishihira H, Tanaka Y, Sasaki Y, Ishida S, Higashino F, and Fujinaga K (1996). Fusion of an ETS-family gene, E1AF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chrom Cancer 15:115-121.
21. Kissane JM, Askin FB, Foulkes M, Stratton LB, and Shirley SF (1983). Ewing's sarcoma of bone: Clinicopathologic aspects of 303 cases from the intergroup Ewing's sarcoma study. Hum Pathol 14:773-779.
22. Krogerman P, Sy MS, and Culp LA (1997). Counter-selection for over-expressed human CD44s in primary tumors versus lung metastases in a mouse fibrosarcoma model. Oncogene 15:1407-1416.
23. Lessnick SL, Braun BS, Denny CT, and May WA (1995). Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. Oncogene 10:423-431.
24. Llombart-Bosch A, Blache R, and Peydro-Olaya A (1978). Ultrastructural study of 28 cases of Ewing's sarcoma: Typical and atypical forms. Cancer 41:1362-1373.
25. May WA, Lessnick SL, Braun BS, Klems M, Lewis BC, Lunsford LB, Hromas R, and Denny CT (1993a). The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more powerful transforming gene than fli-1. Mol Cell Biol 13:7393-7398.
26. May WA, Gishizky ML, Lessnick SL, Lunsford LB, Lewis BC, Delattre O, Zucman J, Thomas G, and Denny CT (1993b). Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by fli1 for transformation. Proc Natl Acad Sci USA 90:5752-5756.
27. May WA, Arvand A, Thompson AD, Braun BS, Wright M, and Denny CT (1997). EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic. Nat Genet 17:495-497.
28. Ohno T, Ouchida M, Lee L, Gatalica Z, Rao VN, and Reddy ESP (1994). The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene 9:3087-3097.
29. Panagopoulos I, Aman P, Fioretos T, Hoglund M, Johansson B, Mandahl N, Heim S, Behrendtz M, and Mitelman F (1994). Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22). Genes Chrom Cancer 11:256-262.
30. Peter M, Couturier J, Pacquement H, Michon J, Thomas G, Magdelenat H, and Delattre O (1997). A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14: 1159-1164.
31. Roussel MF, Davis JN, Cleveland JL, Ghysdael J, and Hiebert SW (1994). Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Oncogene 9:405-415.
32. Shimada H, Newton WA, Soule EH, Qualman SJ, Aoyama C, and Maurer HM (1988). Pathologic features of extraosseous Ewing's sarcoma: A report from the intergroup rhabdomyosarcoma study. Hum Pathol 19:442-453.
33. Sorensen PHB, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, and Denny CT (1994). A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 6:146-151.
34. Sorensen PHB and Triche TJ (1996). Gene fusions encoding chimaeric transcription factors in solid tumours. Sem Cancer Biol 7:3-14.
35. Thompson AD, Braun BS, Arvand A, Stewart SD, May WA, Chen E, Korenberg J, and Denny CT (1996). EAT-2 is a novel SH2 domain containing protein that is up-regulated by Ewing's sarcoma EWS/FLI1 fusion gene. Oncogene 13:2649-2658.
36. Thompson AD, Teitell MA, Arvand A, and Denny CT (In press, 1999). Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH 3T3 cells. Oncogene.
37. Triche TJ (1997). Ewing's sarcoma (Peripheral PNET). In: Bertino JR, editor. The encyclopedia of cancer. San Diego: Academic Press, 652-659.
38. Urano F, Umezawa A, Hong W, Kikuchi H, and Hata J (1996). A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. Biochem Biophys Res Comm 219: 608-612.
39. Wasylyk C, Maira S-M, Sobieszczuk P, and Wasylyk B (1994). Reversion of ras transformed cells by Ets transdominant mutants. Oncogene 9:3665-3673.
40. Wasylyk B, Hagman J, and Gutierrez-Hartmann A (1998). Ets transcription factors: Nuclear effectors of the ras-MAP-kinase signaling pathway. Trends in Biochem Sci 23:213-216.
41. Zinszner H, Albalat R, and Ron D (1994). A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes & Devel 8:2513-2526.
42. Zucman J, Melot T, Desmaze C, Ghysdeal J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc-Carel C, Ambros P, Combaret V, Lenoir G, Aurias A, Thomas G, and Delattre O (1993). Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J 12:4481-4487.